Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $37.0 million.

  • Lifecore Biomedical's Shares Outstanding (Weighted Average) rose 21.21% to $37.0 million in Q2 2025 from the same period last year, while for May 2025 it was $37.0 million, marking a year-over-year increase of 21.21%. This contributed to the annual value of $37.0 million for FY2025, which is 21.21% up from last year.
  • Lifecore Biomedical's Shares Outstanding (Weighted Average) amounted to $37.0 million in FY2025, which was up 21.21% from $30.5 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Shares Outstanding (Weighted Average) registered a high of $37.0 million during FY2025, and its lowest value of $29.3 million during FY2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $32.6 million, with a median of $30.5 million in 2024.
  • Data for Lifecore Biomedical's Shares Outstanding (Weighted Average) shows a peak YoY increased of 21.21% (in 2025) over the last 5 years.
  • Lifecore Biomedical's Shares Outstanding (Weighted Average) (Yearly) stood at $29.3 million in 2021, then climbed by 0.51% to $29.5 million in 2022, then rose by 2.84% to $30.3 million in 2023, then rose by 0.75% to $30.5 million in 2024, then grew by 21.21% to $37.0 million in 2025.